Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-08 Sale |
2023-11-13 2:51 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director |
8,111 | $19 | $154,109 | 0 (Indirect Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:49 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Venezia Rocco Chief Accounting Officer |
14,669 | $19 | $278,711 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:49 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
51,790 | $19 | $984,010 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:47 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Fundaro Paolo Director |
8,111 | $19 | $154,109 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:46 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Richardson Linda M EVP & Chief Commercial Officer |
26,585 | $19 | $505,115 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:46 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Benatti Luca Director |
8,111 | $19 | $154,109 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:45 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | SBLENDORIO GLENN Director |
8,111 | $19 | $154,109 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:44 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | SANTINI GINO Director |
8,111 | $19 | $154,109 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:44 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
8,111 | $19 | $154,109 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:43 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director |
11,625 | $19 | $220,875 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:43 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Gottesdiener Keith Michael Director |
8,111 | $19 | $154,109 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:42 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Ford David A Chief Human Resources Officer |
21,400 | $19 | $406,600 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:42 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel |
33,762 | $19 | $641,478 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:41 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | BRADBURY DANIEL Director |
8,111 | $19 | $154,109 | 0 (Indirect Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:40 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Durso Jerome Benedict CEO |
102,825 | $19 | $1,953,675 | 0 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:40 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
45,244 | $19 | $859,636 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-08 Equity Swap |
2023-11-13 2:51 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director |
678,575 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:49 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Venezia Rocco Chief Accounting Officer |
10,782 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:49 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
28,349 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:47 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Fundaro Paolo Director |
35,794 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:46 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Richardson Linda M EVP & Chief Commercial Officer |
16,706 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:46 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Benatti Luca Director |
25,487 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:45 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | SBLENDORIO GLENN Director |
23,447 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:44 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | SANTINI GINO Director |
23,645 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:44 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
22,304 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:43 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director |
14,766 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:43 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Gottesdiener Keith Michael Director |
24,719 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:42 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Ford David A Chief Human Resources Officer |
15,038 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:42 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel |
22,681 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:41 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | BRADBURY DANIEL Director |
31,360 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:40 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Durso Jerome Benedict CEO |
51,815 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:40 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director |
618,894 | $19 | 0 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:40 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
23,021 | $19 | 0 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-03 4:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel |
771 | $18.96 | 56,443 (Direct) |
View |
| 2023-09-21 Tax Withholding |
2023-09-25 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
908 | $10.8 | 68,265 (Direct) |
View |
| 2023-09-14 Tax Withholding |
2023-09-18 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO |
1,246 | $11.57 | 80,139 (Direct) |
View |
| 2023-08-01 Tax Withholding |
2023-08-03 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel |
771 | $10.5 | 57,214 (Direct) |
View |
| 2023-06-21 Tax Withholding |
2023-06-23 4:04 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
908 | $11.74 | 69,173 (Direct) |
View |
| 2023-06-14 Tax Withholding |
2023-06-16 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO |
1,246 | $12.04 | 81,385 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:40 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Benatti Luca Director |
20,658 | $0 | 46,145 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:40 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | SBLENDORIO GLENN Director |
20,658 | $0 | 44,105 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:40 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Gottesdiener Keith Michael Director |
20,658 | $0 | 45,377 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:39 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Fundaro Paolo Director |
20,658 | $0 | 56,452 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:39 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | SANTINI GINO Director |
20,658 | $0 | 44,303 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:39 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director |
20,658 | $0 | 38,938 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:38 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
20,658 | $0 | 42,962 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:37 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | BRADBURY DANIEL Director |
20,658 | $0 | 52,018 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:37 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director |
20,658 | $0 | 699,233 (Direct) |
View |
| 2023-05-01 Tax Withholding |
2023-05-03 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel |
771 | $17.07 | 57,985 (Direct) |
View |
| 2023-03-21 Tax Withholding |
2023-03-23 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
909 | $14.19 | 70,081 (Direct) |
View |
| 2023-03-14 Tax Withholding |
2023-03-16 4:07 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO |
1,246 | $15.79 | 82,631 (Direct) |
View |
| 2023-02-14 Tax Withholding |
2023-02-16 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Richardson Linda M EVP & Chief Commercial Officer |
386 | $21.21 | 43,291 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel |
918 | $18.76 | 58,756 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 4:06 pm |
N/A 2033-01-27 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Venezia Rocco Chief Accounting Officer |
25,800 | $0 | 41,451 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 4:05 pm |
N/A 2033-01-27 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
38,700 | $0 | 94,990 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 4:05 pm |
N/A 2033-01-27 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Richardson Linda M EVP & Chief Commercial Officer |
32,200 | $0 | 63,677 (Direct) |
View |